Advertisements

Silicone Oil

Quick links to important sections

Silicone Oil

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Silicone Oil

Property Description
Active ingredient Polydimethylsiloxane (PDMS)
Form Injectable solution (Viscous fluid)
Pharmacological class Ophthalmic Tamponade Agent
General purpose Mechanical support and stabilization of ocular structures
Origin Synthetic, Organosilicon compound

What is Silicone Oil and What Type of Agent is it?

Silicone Oil is a highly specialized, synthetic medical material classified as an Ophthalmic Tamponade Agent. This designation places it within a distinct pharmacological class of inert physical supports used primarily in vitreoretinal surgery, rather than a drug that acts via biochemical pathways. The generic substance is known chemically as Polydimethylsiloxane (PDMS), an Organosilicon compound engineered for exceptional biocompatibility within the sensitive ocular environment. The status of PDMS as a well-established ophthalmic agent has been consistently clinically recognized through decades of surgical application in ophthalmology.

Composition, Form, and Unique Physical Properties

The drug is a single-ingredient product where the active substance, Polydimethylsiloxane (PDMS), constitutes the entire medium, presenting as a transparent medical-grade oil or viscous fluid administered via intravitreal injection. This linear polysiloxane is formulated as an injectable solution. A unique and crucial feature of medical Silicone Oil is its variable viscosity and density, which is a differentiating factor that allows specialized formulations to be chosen based on the surgical requirement, such as managing complex retinal tears or detachments.

General Purpose: How Silicone Oil Provides Mechanical Support

The primary general purpose of Silicone Oil is to provide persistent, internal mechanical support through a principle known as tamponade, functioning as an inert physical barrier to hold tissues in place. This allows the material to act as a resilient scaffold, stabilizing delicate structures like the retina for an extended period. This structural stability is crucial as it creates a continuous, supportive environment, facilitating the body’s natural healing processes and helping to achieve sustained anatomical integrity following complex surgical procedures. Its role as a physical agent is foundational to achieving favorable anatomical outcomes in complex surgical cases.

Regulatory References

  1. MedlinePlus
Advertisements

What side effects are possible with Silicone Oil?

Possible Side Effects and Safety Information

The safety profile for Silicone Oil, as documented in authoritative regulatory sources, centers on adverse reactions within the eye and complications related to its physical presence. The product is regulated as a medical device for prescription use only, reflecting the need for professional oversight.

Documented Adverse Reactions

The most common and clinically significant adverse events are primarily classified as Eye Disorders that occur following its use in retinal surgery. These are often related to the intraocular application of the material.

Adverse Event Type Examples of Documented Reactions
Local Ocular Effects Glaucoma (increased intraocular pressure), cataract, keratopathy (corneal damage), retinal re-detachment.
Material-Related Emulsification (breakdown of the oil into small droplets), migration of oil droplets into other eye structures, or beyond the eye.
Serious Risks Unexplained, irreversible visual loss, optic neuropathy (damage to the optic nerve), and silicone oil invasion into the retina or choroidal cavity.

Safety Profile Structure

The official safety information highlights risks tied to the exposure and duration of the oil's presence inside the eye. Risks such as oil emulsification and migration are specifically addressed, indicating that the long-term presence of the material is associated with distinct, documented complications. This structure mandates careful review of both immediate and time-dependent risks related to the product's use as an intraocular tamponade.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Silicone Oil (Polydimethylsiloxane) is defined by severe local complications arising from its excessive volume or prolonged presence as an inert physical agent, not traditional systemic toxicity. Documented manifestations include Elevated Intraocular Pressure (IOP), often leading to Ocular Hypertension, and the breakdown of the oil into droplets known as Silicone Oil Emulsification. Other local presentations are Keratopathy (corneal damage) and **Vitreous Hemorrhage).

These complications are classified as serious and can progress to vision-threatening outcomes, including Glaucoma, Retinal Degeneration, and Unexplained Vision Loss. Patients with pre-existing glaucoma are noted to be at elevated risk for further IOP increase. Vigilant follow-up is required to monitor for signs of these complications.

For these severe outcomes, regulatory guidance mandates that immediate medical attention must be sought. The primary response for a severe overdose state is the Mandated Interventional Action of prompt surgical removal of the oil. No specific chemical antidote is known for Polydimethylsiloxane. Symptomatic and supportive treatment is necessary, such as administering medication to manage elevated IOP.

Advertisements

Therapeutic Uses of Silicone Oil

What Silicone Oil Treats: Main Uses and Benefits

Silicone oil is used in clinical situations involving serious conditions related to the eye. The substance is relevant in surgical settings marked by physiological imbalance related to the retina. Its main therapeutic use is applied in addressing conditions where functional stability is affected, such as complicated retinal detachments, proliferative diabetic retinopathy (PDR), and proliferative vitreoretinopathy (PVR).

Supportive Management for Retinal Stability

This substance is applied in cases where additional physical support is needed following complex eye surgery. It helps address internal structural issues that may become disruptive, contributing to ocular stability during recovery. It provides a mechanical hold that helps maintain the position of the retina and assists with long-term functional stability.


Easing the Burden in Acute Episodes

In clinical settings involving acute or unstable patterns, silicone oil is relevant when supportive management is appropriate for protecting the eye's internal structure. This use is vital in contexts marked by increased tension or trauma, contributing to the management of the eye's internal environment during periods of instability associated with retinal trauma or recurrent detachment episodes.

Quick Fact: Supports management for conditions that significantly impact visual stability and daily functioning.

Advertisements

Eligibility and Restrictions for Use

The eligibility profile for Silicone Oil, when used as an intraocular tamponade fluid, is primarily defined by its regulatory classification as a restricted medical device in official governmental documentation (e.g., by the FDA).

Official Eligibility Constraints

Constraint Type Description based on Regulatory Labeling
Use Restriction Use is restricted by law to prescription use only. The device is further restricted to administration by practitioners who have been specially trained in its use, as specified in the official labeling.
Non-Eligibility/Exclusion Specific conditions may render a patient ineligible for continued use or long-term monitoring as defined in required post-approval studies. Patients with Cytomegalovirus (CMV) retinitis may be excluded from studies tracking oil removal.
Conditional Exclusion Patients who do not meet minimum post-operative success benchmarks are formally excluded from required long-term monitoring studies. This includes patients with less than 75% retinal reattachment one month post-op or visual acuity worse than hand-motion one month post-op.

Summary

Official regulatory documents structure eligibility by first limiting use to specially trained medical professionals, making the general public ineligible. Subsequent constraints are based on clinical outcomes and comorbidities; those with poor early post-operative results or certain complex infections may be ineligible for the standard course of long-term use and monitoring established by the regulator.

Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Silicone Oil (Polydimethylsiloxane), an Ophthalmic Tamponade Agent, is defined by its chemically inert nature and non-systemic route of administration. This means the agent does not undergo significant systemic absorption or metabolic processing. Consequently, the regulatory documentation reflects a definitive absence of the systemic interactions typical of biochemically active drugs.

Documented Systemic Interaction Status

Interaction Category Official Regulatory Status
Metabolic (CYP/Enzyme) Not documented
Transporter-Mediated (P-gp, OATP) Not documented
Exposure-Modifying Substances Not documented
Food, Alcohol, Supplements Not documented

Official government regulatory labeling does not list any specific systemic medicinal products as contraindicated combinations due to interaction risk. The inert profile confirms that Polydimethylsiloxane is not a substrate, inhibitor, or inducer of metabolic enzymes and is not labeled to affect the systemic exposure (AUC or Cmax) of co-administered medicines.

Furthermore, no timing-based administration rules are required by the official labeling for the co-administration of this agent with other systemic medicines. The interaction structure is solely constrained by the product's non-systemic status, resulting in an official profile free of documented systemic drug-drug, drug-food, or population-specific interaction concerns.

Advertisements

Mechanism of Action

Silicone oil is an optically clear, biologically inert polymer classified primarily by its physicochemical properties. Its mechanism of action within the eye is fundamentally physical and does not involve chemical or receptor-mediated signaling pathways.

Mechanical Tamponade and Physical Interface

Within the vitreous cavity, the oil's high surface tension and hydrophobic nature cause it to coalesce into a stable, single phase. This phase exerts a physical force, known as a tamponade effect, against the posterior segment tissues. This interaction maintains a sustained physical interface between the internal limiting membrane and the underlying retinal tissues, resulting in the maintenance of a defined retinal plane.

Fluid Displacement and Compartmentalization

This physical interface establishes a definitive boundary that displaces intraocular fluid from the retinal surface. The resultant compartmentalization impedes the free diffusion and advective transport of soluble factors across the vitreous cavity. This action physically isolates the posterior cavity environment, thereby modulating the local biophysical dynamics.

Advertisements

Dosage and Administration Information

How to Use Silicone Oil

Silicone Oil is used exclusively through Intravitreal Injection, a highly specialized route of administration performed solely in a hospital or surgical setting. This method is required by its clinical classification as an Ophthalmic Tamponade Agent and must be performed by a trained vitreoretinal specialist.

The dosing is unique because it is not a fixed quantity, but is defined as the volume necessary to achieve complete and persistent fill of the eye's vitreous cavity. This required volume is determined intraoperatively by the surgeon based on the patient's individual anatomical needs. The administration itself is a single intraoperative application; it is not taken daily or administered intermittently.

The procedure requires specific preparation, including the use of an automated infusion pump, and is often performed following a fluid-air exchange in the eye. The overall pattern of use is designated as a prolonged retinal tamponade, meaning the treatment is temporary but extended in duration.

Because the substance is inert and non-absorbable by the body, the treatment course requires a subsequent, mandatory surgical procedure known as Silicone Oil Removal (SOR) once retinal stability is achieved. No high-level, standardized volume adjustments are explicitly provided for typical patient populations, as the usage is strictly anatomically and procedurally driven.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Silicone Oil


Evidence for Use in Complicated Retinal Detachment (CRD)

Silicone Oil was studied for its application as an internal support in surgical procedures for individuals facing complex or recurring retinal detachment. The research primarily consisted of Randomized Controlled Trials (RCTs) and Systematic Reviews, involving adults with severe or difficult-to-manage tears and breaks in the retina.

Researchers examined anatomical endpoints, which measured whether the retina was structurally repositioned, and functional measures, such as monitoring changes in visual acuity. Studies monitored the structural condition of the retina during the observation period. Findings described patterns observed in the studies related to the frequency of re-detachment in patients who received this substance.

While the evidence is considered high-level for this indication, comparative evidence is lacking for trials directly comparing various available Silicone Oil viscosities and densities. Furthermore, the optimal timing for the removal of the oil remains a source of heterogeneity across reported study protocols.


Evidence for Use in Proliferative Vitreoretinopathy (PVR)

Evidence for Silicone Oil in Proliferative Vitreoretinopathy (PVR), a condition marked by scarring and contraction on the retina, also relies heavily on Randomized Controlled Trials and subsequent Meta-analyses. Research explored this substance in adults with advanced or recurrent PVR, particularly the more severe forms of the condition.

The studies primarily monitored outcomes focused on tracking anatomical success and the rate of re-operation (secondary surgery rate). Trials described the measurements of anatomical success in patients who received Silicone Oil compared to other support alternatives. Meta-analyses reported patterns related to the need for secondary surgical intervention within the first one to two years of follow-up.

Key Studies & References

  1. Ophthalmic Tamponade Agents (NIH/NCBI Bookshelf)
  2. MedlinePlus Article on Vitreous Hemorrhage and Vitrectomy
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Silicone Oil (FAQ)


Q: What are the most common reasons a doctor might choose Silicone Oil over gas or another substance?

Studies and official information indicate that the agent is often chosen for complex retinal detachments, such as those complicated by Proliferative Vitreoretinopathy (PVR). The oil is also used when a patient cannot maintain the strict head or body positioning required by other support agents. Additionally, unlike gas tamponades, the oil does not expand with changes in altitude, which can be an important factor for patients who need to travel.


Q: How does the presence of Silicone Oil affect my vision immediately after surgery?

The oil’s high index of refraction changes the optics of the eye, which causes a significant shift in vision, commonly resulting in increased farsightedness (hyperopia). Visual clarity may also be temporarily affected by documented postoperative complications, such as swelling of the cornea.


Q: Are there common signs that the Silicone Oil is starting to 'emulsify'?

Emulsification is a documented complication where the oil breaks down into small droplets. While the breakdown is internal, the formation of these droplets is a risk factor associated with the later occurrence of documented adverse reactions. These reactions can include increased pressure inside the eye (glaucoma) or damage to the cornea.


Q: Do I need to change my sleeping position while Silicone Oil is in my eye?

Some medical recommendations advise subjects to maintain a specific postoperative position, such as lying face-up (dorsal position). This practice is followed to manage the risk of the oil shifting forward and making contact with the cornea (the front surface of the eye).


Q: Can having Silicone Oil in my eye cause double vision or light sensitivity?

When the oil migrates into the front chamber of the eye, documented adverse effects can include increased light sensitivity (photophobia) and blurred vision. These symptoms are often related to the oil interfering with the surface of the eye.


Q: Is it normal to see oil bubbles or reflections after the procedure?

It is documented that some patients may notice image distortion, shadows, or halos in their vision. These visual phenomena are typically related to the oil shifting or interfering with the refractive light path, especially if it affects the cornea.


Q: Can Silicone Oil in the eye affect my ability to travel by airplane?

According to official information, the use of medical-grade silicone oil is not linked to contraindications regarding air travel. Unlike other support agents like gas, silicone oil does not expand with changes in cabin pressure or altitude.


Q: What activities are commonly restricted while Silicone Oil is present?

Studies indicate that the typical restrictions focus on avoiding specific head or eye positions that encourage the oil to shift. These restrictions depend on the specific surgical needs.


Q: Can Silicone Oil cause any irritation or redness on the surface of the eye?

If the oil migrates outside of its intended location (such as into the front chamber of the eye), patients may experience eye discomfort or redness. These physical signs can signal surface inflammation.


Q: Is there a maximum amount of time Silicone Oil can safely remain in the eye?

Official research and studies indicate that the risk of documented complications, such as glaucoma and corneal damage (keratopathy), tends to increase with prolonged exposure. For this reason, the agent is considered a temporary treatment that requires mandatory removal.


Q: What should I watch out for that might indicate a problem with the Silicone Oil?

Documented signs associated with complications often involve sudden changes in vision, such as increased blurriness or haziness, or the development of persistent eye discomfort or redness. These symptoms may suggest the oil is causing complications like migration or increased intraocular pressure.


Q: What happens if a small amount of Silicone Oil leaks out of the treated area?

If the oil migrates into the front chamber of the eye, the documented consequences can include an increase in ocular pressure and possible swelling of the cornea. This shifting of the material is an adverse event tracked in official safety profiles.


Q: How commonly does a patient experience a significant side effect from the Silicone Oil?

Studies report that the incidence of the most common adverse reactions, such as glaucoma, recurrent retinal detachment, and corneal damage, differs considerably. Incidences are generally reported across studies to range from 8% to over 40% for the most frequent complications.


Q: Why is my near vision often worse with Silicone Oil in the eye?

Official research indicates that the oil’s refractive properties cause a shift in the eye’s focal point toward farsightedness (hyperopia). This change is documented as a common reason for reduced visual clarity at near-reading distances.


Q: How effective is Silicone Oil removal at fully restoring the original vision level?

Visual acuity often improves after the oil is removed because the refractive errors it caused are mitigated. However, studies have also tracked the occurrence of unexplained, irreversible visual loss following the removal procedure as a possible outcome.


Q: How do doctors monitor the condition of the retina while the oil is present?

Postoperative monitoring typically includes a complete ophthalmic examination. This assessment checks the patient’s visual acuity, ocular tension (intraocular pressure), and looks for specific complications such as oil emulsification, cataract formation, and corneal damage.


Q: Will I need special glasses or corrective lenses because of the Silicone Oil?

Corrective lenses are commonly utilized to compensate for the change in vision. The use of these lenses helps to manage the vision changes until the mandatory removal procedure is performed.


Q: Is there a specific period where the risks associated with Silicone Oil are highest?

Clinical studies note that while the incidence of complications increases the longer the oil remains in the eye, certain documented complications can begin to be noticed as early as the first week postoperatively.


Q: Can the oil affect how quickly the eye heals after the initial surgery?

The oil's primary function is to provide persistent physical support and stability, which facilitates the eye's natural healing processes. Some literature has reported concerns that the oil’s presence may affect the distribution and clearance of therapeutic agents or inflammatory factors.


Q: What is the typical success rate described in studies when Silicone Oil is used?

Anatomical success rates reported in studies vary significantly, as they depend heavily on the specific complexity of the underlying eye condition. For complicated retinal detachments, studies have reported reattachment rates ranging from 58% to over 79% at various follow-up periods.


Q: What is the average duration the Silicone Oil remains in the eye according to medical guidelines?

Official guidelines do not define a single average duration, as the timing for the mandatory removal is based on the surgeon’s assessment of retinal stability. However, studies often report mean durations in patients, with figures typically clustering around 6 to 7 months.


Q: Will I be able to feel the Silicone Oil inside my eye?

While the inert substance itself is not reported to be felt, if the oil causes complications like migration or increased pressure, patients may report associated sensations. These can include pressure, eye discomfort, or a foreign body sensation.

Advertisements

How should Silicone Oil be stored and disposed of?

How to Store and Dispose of Silicone Oil

Official regulatory guidelines strictly define the conditions necessary for storing and handling ophthalmic Silicone Oil (Polydimethylsiloxane) to ensure stability and safety.

Required Storage and Stability

The product must be stored in its tightly closed, properly labelled container at cool or room temperature, typically between 8 C and 24 C, and protected from sources of heat and static electricity. The labeled shelf-life is generally 2 years under these conditions. A mandated precaution is to Keep out of reach of children.

Handling and Disposal Rules

Handling instructions note to not shake the product prior to use. Disposal is governed by strict rules: any portion of the product remaining after the surgical procedure must be immediately discarded. Furthermore, environmental rules require that the product be kept away from drains, surface water, and ground water, with disposal following the local municipality’s separated collection system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Silicone Oil found in:

A-Z Index: